These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 32634717)

  • 1. Application of Artificial Intelligence in COVID-19 drug repurposing.
    Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence (AI) applications for COVID-19 pandemic.
    Vaishya R; Javaid M; Khan IH; Haleem A
    Diabetes Metab Syndr; 2020; 14(4):337-339. PubMed ID: 32305024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting the arsenal against COVID-19 through computational drug repurposing.
    Ciliberto G; Cardone L
    Drug Discov Today; 2020 Jun; 25(6):946-948. PubMed ID: 32304645
    [No Abstract]   [Full Text] [Related]  

  • 6. Fight against novel coronavirus: A perspective of medicinal chemists.
    Amin SA; Jha T
    Eur J Med Chem; 2020 Sep; 201():112559. PubMed ID: 32563814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges.
    Parvathaneni V; Gupta V
    Life Sci; 2020 Oct; 259():118275. PubMed ID: 32818545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combating devastating COVID-19 by drug repurposing.
    Pawar AY
    Int J Antimicrob Agents; 2020 Aug; 56(2):105984. PubMed ID: 32305589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 10. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
    Sharma K; Morla S; Goyal A; Kumar S
    Life Sci; 2020 Oct; 259():118169. PubMed ID: 32738360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
    Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
    PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence in COVID-19 drug repurposing.
    Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
    Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence and machine learning to fight COVID-19.
    Alimadadi A; Aryal S; Manandhar I; Munroe PB; Joe B; Cheng X
    Physiol Genomics; 2020 Apr; 52(4):200-202. PubMed ID: 32216577
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
    Ackerman EE; Shoemaker JE
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
    Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
    Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review.
    Naseem M; Akhund R; Arshad H; Ibrahim MT
    J Prim Care Community Health; 2020; 11():2150132720963634. PubMed ID: 32996368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches Based on Artificial Intelligence and the Internet of Intelligent Things to Prevent the Spread of COVID-19: Scoping Review.
    Adly AS; Adly AS; Adly MS
    J Med Internet Res; 2020 Aug; 22(8):e19104. PubMed ID: 32584780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.